[Federal Register Volume 63, Number 136 (Thursday, July 16, 1998)]
[Rules and Regulations]
[Pages 38303-38304]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-18956]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Parts 522 and 556


Implantation or Injectable Dosage Form New Animal Drugs; 
Spectinomycin Solution; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a final 
rule that appeared in the Federal Register of May 1, 1998 (63 FR 
24106). The document amended the animal drug regulations to reflect 
approval of a new animal drug application (NADA)

[[Page 38304]]

filed by Pharmacia & Upjohn Co. The NADA provides for veterinary 
prescription use of AdspecTM (spectinomycin) sterile 
solution for cattle. The document incorrectly listed the tolerance for 
spectinomycin residues in cattle muscle. This document corrects that 
error.

EFFECTIVE DATE: July 16, 1998.

FOR FURTHER INFORMATION CONTACT: George K. Haibel, Center for 
Veterinary Medicine (HFV-133), Food and Drug Administration, 7500 
Standish Pl., Rockville, MD 20855, 301-594-1644.
SUPPLEMENTARY INFORMATION: In FR Doc. 98-11686 appearing on page 24106 
in the Federal Register of Friday, May 1, 1998, the following 
correction is made:


Sec. 556.600  [Corrected]

    1. On page 24107, in the second column, in Sec. 556.600 
Spectinomycin, in paragraph (c), in the fourth line, ``0.4'' is 
corrected to read ``0.25''.

    Dated: July 9, 1998.
 Stephen F. Sundlof,
 Director, Center for Veterinary Medicine.
[FR Doc. 98-18956 Filed 7-15-98; 8:45 am]
BILLING CODE 4160-01-F